Company news
AtriCure, Inc. news in 2020
AtriCure, Inc.'s news releases, calls and decks from 2020, newest first.
AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference
December 13, 2020
AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
November 18, 2020
AtriCure Reports Third Quarter 2020 Financial Results
November 4, 2020
AtriCure to Announce Third Quarter 2020 Financial Results
October 12, 2020
AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference
August 31, 2020
AtriCure Announces Angie Wirick as Chief Financial Officer
August 5, 2020
AtriCure Reports Second Quarter 2020 Financial Results
July 27, 2020
AtriCure to Announce Second Quarter 2020 Financial Results
July 6, 2020
AtriCure Announces Proposed Public Offering of Common Stock
May 10, 2020
AtriCure Announces Pricing of Public Offering of Common Stock
May 10, 2020
AtriCure Announces Results from CONVERGE IDE Clinical Trial
May 7, 2020
AtriCure Announces Investor Update Webcast on May 8, 2020 in Conjunction with the 41st Annual Heart Rhythm Society (HRS) Virtual Meeting
April 29, 2020
AtriCure Reports First Quarter 2020 Financial Results
April 28, 2020
AtriCure to Announce First Quarter 2020 Financial Results
April 14, 2020
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
April 12, 2020
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
April 8, 2020
AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results
February 17, 2020
AtriCure to Participate at the SVB Leerink 9th Annual Global Healthcare Conference
February 2, 2020
AtriCure to Announce Fourth Quarter and Full Year 2019 Financial Results
January 27, 2020
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2019, Provides Financial Outlook for 2020
January 12, 2020
AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access Protocol
January 6, 2020
Calls in 2020
Decks in 2020
- Investor Presentation (November 2020)
Investor deck · 23 slides · Nov 5, 2020
- Investor Presentation (April 2020)
Investor deck · 25 slides · Apr 29, 2020
- Investor Presentation (January 2020)
Investor deck · 25 slides · Jan 13, 2020